The effects of caffeine and aspirin on mood and performance - PubMed (original) (raw)
Affiliations
- PMID: 3680601
Clinical Trial
The effects of caffeine and aspirin on mood and performance
H R Lieberman et al. J Clin Psychopharmacol. 1987 Oct.
Abstract
Caffeine, in addition to being a food constituent, is also a common analgesic adjuvant that is used in combination with aspirin in certain over-the-counter preparations. Caffeine has previously been shown to significantly improve certain aspects of human performance, particularly sustained vigilance, when administered in low and moderate doses (32 to 256 mg). We therefore attempted to determine whether caffeine, in the dose (64 mg) found in some over-the-counter drugs, retains this beneficial property when combined with aspirin. We also measured self-reported mood state, using various standardized questionnaires, since caffeine has been reported to have both beneficial and adverse effects on alertness and anxiety. We observed that caffeine (64 mg), when added to aspirin (800 mg), significantly improves vigilance performance and increases self-reported efficiency when compared with either placebo or aspirin alone. As previously reported, this caffeine dose alone significantly increased vigilance and decreased reaction time. No adverse effects of caffeine were detected on any of the parameters that were assessed. This study therefore demonstrated that the addition of caffeine to aspirin, in a dose commonly employed in over-the-counter drugs, has significant beneficial consequences with respect to mood and performance.
Similar articles
- Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
Lieberman HR, Tharion WJ, Shukitt-Hale B, Speckman KL, Tulley R. Lieberman HR, et al. Psychopharmacology (Berl). 2002 Nov;164(3):250-61. doi: 10.1007/s00213-002-1217-9. Epub 2002 Sep 5. Psychopharmacology (Berl). 2002. PMID: 12424548 Clinical Trial. - Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.
Hewlett P, Smith A. Hewlett P, et al. Hum Psychopharmacol. 2007 Aug;22(6):339-50. doi: 10.1002/hup.854. Hum Psychopharmacol. 2007. PMID: 17514640 - Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
Killgore WD, Rupp TL, Grugle NL, Reichardt RM, Lipizzi EL, Balkin TJ. Killgore WD, et al. J Sleep Res. 2008 Sep;17(3):309-21. doi: 10.1111/j.1365-2869.2008.00654.x. Epub 2008 Jun 2. J Sleep Res. 2008. PMID: 18522689 Clinical Trial. - Effects of caffeine on human behavior.
Smith A. Smith A. Food Chem Toxicol. 2002 Sep;40(9):1243-55. doi: 10.1016/s0278-6915(02)00096-0. Food Chem Toxicol. 2002. PMID: 12204388 Review. - Ephedrine, caffeine and aspirin: "over-the-counter" drugs that interact to stimulate thermogenesis in the obese.
Dulloo AG, Miller DS. Dulloo AG, et al. Nutrition. 1989 Jan-Feb;5(1):7-9. Nutrition. 1989. PMID: 2520262 Review. No abstract available.
Cited by
- The Safety of Ingested Caffeine: A Comprehensive Review.
Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA. Temple JL, et al. Front Psychiatry. 2017 May 26;8:80. doi: 10.3389/fpsyt.2017.00080. eCollection 2017. Front Psychiatry. 2017. PMID: 28603504 Free PMC article. Review. - The influence of caffeine on human EEG under resting conditions and during mental loads.
Dimpfel W, Schober F, Spüler M. Dimpfel W, et al. Clin Investig. 1993 Mar;71(3):197-207. doi: 10.1007/BF00180102. Clin Investig. 1993. PMID: 8481621 Clinical Trial. - Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.
Edgar CJ, Pace-Schott EF, Wesnes KA. Edgar CJ, et al. Hum Psychopharmacol. 2009 Jul;24(5):371-89. doi: 10.1002/hup.1034. Hum Psychopharmacol. 2009. PMID: 19565524 Free PMC article. Review. - Stimulant drugs and vigilance performance: a review.
Koelega HS. Koelega HS. Psychopharmacology (Berl). 1993;111(1):1-16. doi: 10.1007/BF02257400. Psychopharmacology (Berl). 1993. PMID: 7870923 Review. - Effects of caffeine or diphenhydramine on visual vigilance.
Fine BJ, Kobrick JL, Lieberman HR, Marlowe B, Riley RH, Tharion WJ. Fine BJ, et al. Psychopharmacology (Berl). 1994 Mar;114(2):233-8. doi: 10.1007/BF02244842. Psychopharmacology (Berl). 1994. PMID: 7838913 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials